000			03574nam a22003855i 4500
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
988			_aSpringer_Medicine_2018
999			_c343898 _d343898 _x1
001			343898
003			ES-MaUEC
005			20230102120152.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			171106s2018 gw | s |||| 0|eng d
020			_a9783319666792
024	7		_a10.1007/978-3-319-66679-2 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aR857.T55 _b2018 EB
245	1	0	_aCellular and Molecular Approaches to Regeneration and Repair _cedited by Paul A. Lapchak, John H. Zhang.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (VII, 541 páginas) _b46 ilustraciones, 45 ilustraciones a color
490	1		_aSpringer Series in Translational Stroke Research, _x2363-958X
490			_aMedicine (Springer-11650)
520			_aThis book discusses recent advances in the field of translational stroke research. The editors have designed the book to provide new insight into the importance of regeneration and repair mechanisms for stroke victims. The editors have brought together a talented group of international stroke researchers and clinicians to contribute to this volume, which is written for students, researchers and physicians in biotechnology, neurosciences, neurology, neuroradiology and neurosurgery. Throughout the world, stroke is still a leading cause of mortality and morbidity; there are 152,000 strokes in the United Kingdom, 62,000 in Canada, and approximately 15 million people worldwide. Large communities of stroke survivors are eagerly awaiting scientific advances in translational stroke research related to regeneration and recovery of function that would offer new therapeutics for rehabilitation and regeneration utilizing novel stem cell and molecular-based approaches. This volume will allow the reader to understand the future of stroke treatment from its inception in the laboratory through to clinical trial design. The reader will learn about the recent advances made in these areas related to basic and applied stroke research and their translational potential. Dr. Paul A. Lapchak is Professor of Neurology and Director of Translational Research in the Departments of Neurology & Neurosurgery at Cedars-Sinai Medical Center in Los Angeles CA, USA. Dr. Lapchak is an internationally recognized expert conducting translational drug development research for ischemic and hemorrhagic stroke. Dr. John H. Zhang is Professor of Anesthesiology, Neurosurgery, Neurology, and Physiology, and Director, Center for Neuroscience Research at Loma Linda University School of Medicine, Loma Linda, CA, USA. Dr. Zhang is an internationally recognized expert working on drug development for hemorrhagic stroke.
650		7	_2embne _9143820 _aIngeniería biomédica
700	1		_aLapchak, Paul A. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aZhang, John H. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _988233
776	0	8	_iPrinted edition: _z9783319666785
776	0	8	_iPrinted edition: _z9783319666808
776	0	8	_iPrinted edition: _z9783319882994
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-66679-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _a_alco _a_vill _b02/2019 _cm _dz _feng _ggw _h0